Baohui Han

14.8k total citations · 3 hit papers
458 papers, 7.7k citations indexed

About

Baohui Han is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Baohui Han has authored 458 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 305 papers in Pulmonary and Respiratory Medicine, 276 papers in Oncology and 99 papers in Molecular Biology. Recurrent topics in Baohui Han's work include Lung Cancer Treatments and Mutations (224 papers), Lung Cancer Research Studies (164 papers) and Lung Cancer Diagnosis and Treatment (145 papers). Baohui Han is often cited by papers focused on Lung Cancer Treatments and Mutations (224 papers), Lung Cancer Research Studies (164 papers) and Lung Cancer Diagnosis and Treatment (145 papers). Baohui Han collaborates with scholars based in China, United States and United Kingdom. Baohui Han's co-authors include Liyan Jiang, Yanwei Zhang, Runbo Zhong, Jianlin Xu, Hua Zhong, Yizhuo Zhao, Yuqing Lou, Jiayuan Sun, Jiajun Teng and Wei Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Baohui Han

434 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis

2009 436 citations Yizhuo Zhao, Baohui Han et al. profile →
Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

2021 174 citations Tianqing Chu, Runbo Zhong et al. profile →
One-dimensional multicomponent nanofibers engineered as heterostructures for electromagnetic stealth applications

2025 25 citations Baohui Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Baohui Han China	42	4.6k	3.9k	1.9k	1.4k	779	458	7.7k
Fumihiro Tanaka Japan	48	4.4k 0.9×	3.8k 1.0×	2.3k 1.2×	1.5k 1.0×	1.3k 1.6×	404	8.7k
Gérard Zalcman France	39	3.0k 0.7×	3.5k 0.9×	2.1k 1.1×	890 0.6×	539 0.7×	299	6.7k
Nicolas Girard France	47	4.0k 0.9×	3.6k 0.9×	1.4k 0.7×	1.3k 0.9×	1.0k 1.3×	417	8.3k
Sylvie Lantuéjoul France	45	3.7k 0.8×	3.2k 0.8×	2.1k 1.1×	1.2k 0.9×	662 0.8×	154	6.9k
Kenji Sugio Japan	47	3.3k 0.7×	3.2k 0.8×	2.7k 1.4×	1.1k 0.8×	915 1.2×	276	7.1k
Koji Tsuta Japan	54	5.4k 1.2×	4.5k 1.1×	3.2k 1.7×	1.9k 1.4×	988 1.3×	301	9.9k
Margarita Majem Spain	31	6.1k 1.3×	7.5k 1.9×	1.6k 0.8×	1.4k 1.0×	701 0.9×	214	9.7k
Koichi Azuma Japan	42	3.0k 0.7×	3.3k 0.8×	1.5k 0.8×	949 0.7×	378 0.5×	266	6.2k
Tomoyuki Yokose Japan	43	3.3k 0.7×	2.6k 0.7×	1.2k 0.6×	821 0.6×	1.1k 1.4×	272	6.6k
Tae‐You Kim South Korea	48	2.5k 0.5×	4.3k 1.1×	2.0k 1.1×	1.5k 1.1×	1.0k 1.3×	189	7.6k

Countries citing papers authored by Baohui Han

Since Specialization

Citations

This map shows the geographic impact of Baohui Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baohui Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baohui Han more than expected).

Fields of papers citing papers by Baohui Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baohui Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baohui Han. The network helps show where Baohui Han may publish in the future.

Co-authorship network of co-authors of Baohui Han

This figure shows the co-authorship network connecting the top 25 collaborators of Baohui Han. A scholar is included among the top collaborators of Baohui Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baohui Han. Baohui Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yanwei, Beibei Sun, Jun Lü, et al.. (2024). Multimodal fusion of liquid biopsy and CT enhances differential diagnosis of early-stage lung adenocarcinoma. npj Precision Oncology. 8(1). 50–50. 8 indexed citations

Han, Baohui, et al.. (2024). Effect of Y contents on surface wetting and interfacial behavior of Al-Si-Cu-Zn-Ni-xY brazing filler alloys on 7072 aluminum alloy. Materials Characterization. 220. 114683–114683. 2 indexed citations

Han, Baohui, et al.. (2024). Flow stokes microscopy for high throughput classification of marine particles. Optics & Laser Technology. 176. 111000–111000. 5 indexed citations

Pan, Feng, et al.. (2024). Physicians’ Knowledge of Pulmonary Rehabilitation in China: A Cross-Sectional Study. International Journal of COPD. Volume 19. 121–131. 2 indexed citations

Xu, Jianlin, Shuyuan Wang, Runbo Zhong, et al.. (2023). On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancer. Frontiers in Immunology. 14. 1173025–1173025. 3 indexed citations

Lü, Jun, Yuqing Lou, Yanwei Zhang, et al.. (2023). Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery. International Journal of Nanomedicine. Volume 18. 263–276. 10 indexed citations

Cheng, Ying, Qing Zhou, Baohui Han, et al.. (2023). NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer. Lung Cancer. 178. 87–95. 6 indexed citations

Lü, Jun, Huiping Qiang, Mingfang Lu, et al.. (2023). Anlotinib Combined with Anti‐PD1 Potentiates Anti‐Tumor Immunity via Immunogenic Cell Death and Macrophage Reprogramming. Advanced Therapeutics. 6(11). 5 indexed citations

Cheng, Ying, Qiming Wang, Kai Li, et al.. (2023). Third‐line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases: A post hoc analysis of ALTER1202, a randomized, double‐blind phase 2 study. SHILAP Revista de lepidopterología. 2(3). 181–190. 4 indexed citations

10.

Liu, Ying, Ying Cheng, Qiming Wang, et al.. (2021). Effectiveness of anlotinib in patients with small‐cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study. Thoracic Cancer. 12(22). 3039–3045. 8 indexed citations

11.

Cheng, Ying, Qiming Wang, Kai Li, et al.. (2021). Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial. Cancer Medicine. 11(4). 1081–1087. 15 indexed citations

12.

Pan, Feng, et al.. (2021). Utility and Safety of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Isolated Mediastinal Masses. Journal of Multidisciplinary Healthcare. Volume 14. 2047–2052.

13.

Cheng, Ying, Baohui Han, Kai Li, et al.. (2020). Effect of anlotinib as a third‐ or further‐line therapy in advanced non‐small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial. Cancer Medicine. 9(8). 2621–2630. 21 indexed citations

14.

Xu, Jianlin, Rong Qiao, Yizhuo Zhao, et al.. (2020). Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of Oncology. 2020. 1–7. 6 indexed citations

15.

Xu, Wei, Jun Lü, Qiang Zhao, et al.. (2019). Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer. Disease Markers. 2019. 1–7. 41 indexed citations

16.

Wang, Yiyang, Difan Zheng, Jiajie Zheng, et al.. (2018). Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy. Journal of Cancer Research and Clinical Oncology. 144(6). 1015–1023. 26 indexed citations

17.

Wang, Yiyang, Rui Wang, Difan Zheng, et al.. (2017). The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation. Journal of Cancer Research and Clinical Oncology. 143(10). 2095–2104. 13 indexed citations

18.

Zhang, Yanwei, Jianlin Xu, Yuqing Lou, et al.. (2016). Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non‐small‐cell lung cancer patients with EGFR mutations. International Journal of Cancer. 140(7). 1645–1652. 36 indexed citations

19.

Li, Longyun, Wei Zhong, Meilin Liao, et al.. (2012). [A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China].. SHILAP Revista de lepidopterología. 15(6). 332–9. 5 indexed citations

20.

Han, Baohui, et al.. (2002). [The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer].. PubMed. 25(12). 727–31. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact